EU Approves German State Aid for Sanofi Frankfurt Insulin Plant

• European Commission approved German federal, Hesse and Frankfurt public support for Sanofi’s new Frankfurt insulin plant in September 2026.
• Construction began today; full insulin active ingredient production is planned for 2032, subject to licensing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-431012), on October 26, 2026, and is solely responsible for the information contained therein.